Gábor Nagy

Chief Chemist

University Name

Hungary

Research Interests

Explore related searches

Professors in Hungary

Contact this professor

LinkedIn

Google Scholar

About

Gábor Nagy is the Chief Chemist at Scanomed in Hungary. His research focuses on the development and evaluation of radiolabeled compounds for cancer imaging and therapy, with recent publications addressing therapeutic efficacy in preclinical models, novel chelators for radiolabeling, and the assessment of hypoxia-sensitive probes. His work contributes significantly to the advancement of diagnostic and therapeutic strategies in oncology.

Articles (6)

AAZTA‐Like Ligands Bearing Phenolate Arms as Efficient Chelators for 68Ga Labelling in vitro and in vivo

Year:

2023

In Vivo Preclinical Assessment of the VEGF Targeting Potential of the Newly Synthesized [52Mn]Mn-DOTAGA-Bevacizumab Using Experimental Cervix Carcinoma Mouse Model

Year:

2023

Evaluation of the therapeutic efficacy of 213Bi-labelled DOTA-conjugated alpha-melanocyte stimulating hormone peptide analogues in melanocortin-1 receptor positive preclinical melanoma model

Year:

2023

Synthesis, Physicochemical, Labeling and In Vivo Characterization of <sup>44</sup>Sc-Labeled DO3AM-NI as a Hypoxia-Sensitive PET Probe

Year:

2022

Synthesis, radiolabeling, and pre-clinical evaluation of [44Sc]Sc-AAZTA conjugate PSMA inhibitor, a new tracer for high-efficiency imaging of prostate cancer

Year:

2021

<i>In Vivo</i> Imaging of Hypoxia and Neoangiogenesis in Experimental Syngeneic Hepatocellular Carcinoma Tumor Model Using Positron Emission Tomography

Year:

2020

Collaborators (4)

Anikó Fekete

University of Debrecen

HUNGARY

Lorenzo TEI

Full Professor

Università degli Studi del Piemonte Orientale Amedeo Avogadro

ITALY

Gyorgy Trencsenyi

University of Debrecen

HUNGARY

Gyula Tircsó

University of Debrecen

HUNGARY

Social connections

How do I reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI